Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids

Anders Thelin*, Elisabeth Peterson, Julie L. Hutson, Alun D. McCarthy, Johan Ericsson, Gustav Dallner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

The effects of squalestatin 1 on rat brain and liver homogenates and on Chinese hamster ovary tissue culture cells have been investigated. This compound effectively inhibits squalene biosynthesis in a highly selective manner. Cytoplasmic farnesyl pyrophosphate and geranylgeranyl pyrophosphate synthases are not affected, which is also the case for microsomal cis-prenyltransferase. In tissue culture cells, squalestatin 1 inhibits cholesterol biosynthesis completely, but does not alter dolichol synthesis or protein isoprenylation to a great extent. Incorporation of [3H]mevalonate into ubiquinone-9 and -10 increases 3-4-fold, probably as a result of increased synthesis of this lipid. Squalestatin 1 appears not only to be an effective inhibitor of cholesterol biosynthesis, but also to be more specific than other inhibitors used earlier in various in vitro and in vivo systems.

Original languageEnglish
Pages (from-to)245-249
Number of pages5
JournalBiochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Volume1215
Issue number3
DOIs
Publication statusPublished - 8 Dec 1994
Externally publishedYes

Keywords

  • Cholesterol
  • Dolichol
  • Protein isoprenylation
  • Squalene synthase
  • Squalestatin 1
  • Ubiquinone

Fingerprint

Dive into the research topics of 'Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids'. Together they form a unique fingerprint.

Cite this